Brought to you by 
CoLucid Pharmaceuticals raises $16.5mm in Series A round
03 Feb 2006
Executive Summary
CoLucid Pharmaceuticals closed a $16.5mm Series A financing that was co-led by Pappas Ventures, which seeded and founded the company in August 2005, and Domain Associates. Other investors included Triathlon Medical Ventures and Pearl Street Venture Funds.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
CoLucid Pharmaceuticals raises $16.5mm in Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice